Taratec and Spotfire Announce Partnership to Bring Analytics to Drug Safety

Taratec and Spotfire(R) announced today a strategic partnership designed to help pharmaceutical companies better analyze their Drug Safety data. Taratec has embedded their unique approach to Pharmacovigilance and Signal Detection into Guided Analysis based on Spotfire’s DecisionSite software. By combining the power of Taratec’s expertise and unique methodologies with Spotfire’s visual analysis and data interactivity, Taratec customers can react more quickly to safety concerns once drugs have been released to market.


Taratec is an industry-leading consultancy that provides regulatory compliance services to address the unique business and information technology challenges faced by life science companies. Taratec’s clients are the leading innovators in the pharmaceutical, biotechnology, and medical device industries.


Spotfire DecisionSite offers an interactive, visual approach to data analysis that empowers individuals to quickly and easily see trends, patterns, and unanticipated relationships in data from many sources. By leveraging Spotfire’s Guided Analysis, Taratec has adapted DecisionSite specifically for detection of potential signals or trends within drug safety data. The Guides enhance DecisionSite to allow clinicians and epidemiologists to quickly and intuitively analyze clinical data with little IT support, typically saving significant time and money. The joint solution can be used independently or in conjunction with any data mining application, depending on unique customer needs.

 

“Our partnership with Spotfire allows us to bring clarity and insight to the process of signal detection,” said Steve Jolley, vice president, Pharmacovigilance, Taratec. “The joint solution can analyze vast quantities of pharmacovigilance data and highlight the clinical significance of potential signals.”

 

“With DecisionSite, Taratec customers can visualize multiple variables at once, dynamically adding new data as it becomes available and thereby uncovering insights that spreadsheets can’t deliver,” said Christian Marcazzo, senior director of life science analytics for Spotfire. “The result is a new and powerful way for pharmaceutical companies to monitor drug safety once products have been released.”

 

About Taratec
Taratec is a leading life science consultancy that provides integrated business, information technology, and regulatory compliance services to innovative pharmaceutical, biotechnology, and medical device organizations around the world. With an extensive suite of services and solutions, Taratec enables life science companies to bring products to market sooner and improve manufacturing efficiency while achieving compliance with FDA regulations. Taratec is headquartered in Bridgewater, NJ, with a major operations center in San Juan, Puerto Rico. For more information, please visit www.taratec.com .

About Spotfire
For thousands of business professionals faced with day-to-day decisions, Spotfire analytics offers the platinum user experience for visually interacting with information. Distinguished by its intuitive ease and analytic power, Spotfire software rapidly reveals unseen threats and illuminates new opportunities, creating significant economic value. Spotfire’s customers include industry leaders among the Global 2000 that have deployed Spotfire analytics to gain an information advantage over their competitors. For more information, visit http://www.spotfire.com .

Spotfire and DecisionSite are trademarks or registered trademarks of Spotfire, Inc., except in the European Community where Spotfire and DecisionSite are trademarks of Spotfire AB. Other company or product names may be the trademarks of their respective owners.

 

BRIDGEWATER, N.J., June 28 /PRNewswire/